Rua Bioscience Limited (NZE:RUA)
New Zealand · Delayed Price · Currency is NZD 0.0260
0.00 (0.00%)
Nov 12, 2026, 4:35 PM NZDT
Rua Bioscience Market Cap
Rua Bioscience has a market cap or net worth of 8.83 million as of November 11, 2026. It is the 44,861st most valuable company in the world and the 97th biggest in New Zealand. Its market cap has increased by 6.36% in one year.
Market Cap
8.83M
Enterprise Value
10.05M
Revenue
2.81M
Global Rank
Country Rank
#97 New Zealand
PE Ratio
n/a
ChartMarket Cap Chart
Since October 22, 2020, Rua Bioscience's market cap has decreased from 95.21M to 8.83M, a decrease of -90.73%. That is a compound annual growth rate of -32.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 8.83M | -6.76% |
| Dec 31, 2025 | 9.47M | 54.80% |
| Dec 31, 2024 | 6.11M | -67.78% |
| Dec 29, 2023 | 18.98M | -44.14% |
| Dec 30, 2022 | 33.97M | -45.52% |
| Dec 31, 2021 | 62.37M | -25.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fisher & Paykel Healthcare Corporation | 28.45B |
| EBOS Group | 4.43B |
| Ryman Healthcare | 1.88B |
| Summerset Group Holdings | 1.53B |
| Pacific Edge | 329.10M |
| Green Cross Health | 274.72M |
| Radius Residential Care | 116.22M |
| Third Age Health Services | 40.42M |